Evidence map›Paper›PMID 36178570›Full record

ArticleAnnals of nuclear medicine2022

Chronic fluoxetine enhances extinction therapy for PTSD by evaluating brain glucose metabolism in rats: an [

Jing Liu, Jun Yu, Hong Biao Liu, Qiong Yao, Ying Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of nuclear medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jing LiuDepartment of Nuclear Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
Jun YuDepartment of Nuclear Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
Hong Biao LiuDepartment of Nuclear Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
Qiong YaoDepartment of Nuclear Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
Ying ZhangDepartment of Nuclear Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China. zhangying5401@zju.edu.cn.ORCID http://orcid.org/0000-0002-5939-0440
Second Affiliated Hospital of Zhejiang University · CN

Funding

National Natural Science Foundation of China 81501508Natural Science Foundation of Zhejiang Province LQ14H180003the Ministry of Science and Technology of China 2016YFA0100902
6 · The paper itself

Abstract

backgroundRecent studies suggest that selective serotonin reuptake inhibitors (SSRIs) and exposure therapies have been used to reduced footshock-induced posttraumatic stress disorder (PTSD) symptoms. However, the therapeutic effect of the combination of SSRIs treatment with exposure therapy remains a matter of debate. This study aimed to evaluate these therapeutic effect through the behavioural and the neuroimaging changes by positron emission tomography (PET) in model rats.

methodsPavlovian fear conditioning paradigm to establish model rats, and serial PET imaging with 2-deoxy-2-[

resultsWe report that fear conditioning increased glucose metabolism in the right amygdala and left primary visual cortex but decreased glucose metabolism in the left primary somatosensory cortex. After extinction retrieval, there was increased [

conclusionsChronic fluoxetine enhanced the effects of extinction training in a rat model of PTSD. In vivo PET imaging may provide a promising approach for evaluation chronic fluoxetine treatment of PTSD.

Indexed as

FluoxetineStress Disorders, Post-TraumaticAnimalsBrainFluorodeoxyglucose F18GlucoseHippocampusPositron-Emission TomographyRatsSelective Serotonin Reuptake InhibitorsFluorodeoxyglucose F18FluoxetineGlucoseSelective Serotonin Reuptake Inhibitors2-Deoxy-2-[18F]fluoro-D-glucoseFluoxetineHippocampusPositron emission tomographyPosttraumatic stress disorder

Identifiers

PMID36178570
OpenAlexW4298088981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.